(Q31016839)

28 June 2017

Study conduct, monitoring and data management in a trinational trial: the OPTIMA model (English)

1 reference

28 June 2017

0 references

Tassos C Kyriakides

1

1 reference

28 June 2017

Abdel Babiker

2

1 reference

28 June 2017

Joel Singer

3

1 reference

28 June 2017

Mirek Piaseczny

4

1 reference

28 June 2017

John Russo

5

1 reference

28 June 2017

1 January 2004

1 reference

28 June 2017

1 reference

28 June 2017

1

1 reference

28 June 2017

277-281

1 reference

28 June 2017

3

1 reference

An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial.

28 June 2017

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN022OA

The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN022OA

An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN022OA

Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN022OA

The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774504CN022OA

10.1191/1740774504CN022OA

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference